AI-powered ITE hearing aid combines discreet design, fabric-wrapped charging case, and versatile connectivity to enhance daily communication.
SHENZHEN, China, Aug. 25, 2025 /PRNewswire/ — Cearvol today announced the launch of Wave Lite, its latest ITE (In-The-Ear) hearing aid, driven by advanced AI processing that enhance daily communication and confidence, supported by a discreet design and a fabric-wrapped charging case.
“Wave Lite embodies our mission to deliver technology that empowers users with comfort and elegance,” said Vincent, CEO of Cearvol.
Delivering up to 40dB gain, Wave Lite supports mild to moderately severe hearing loss with clear, balanced sound. AI acoustic management with clear speech enhance enables background noise reduction, feedback cancellation, and own voice reduction —raising Cearvol’s reputation for developing some of the best OTC hearing aids. Wave Lite supports AUX-IN connection for TV viewing, in-flight entertainment, gym workouts, or personal music, ensuring clear and private sound in any setting.
Key Highlights:
Bluetooth Streaming & Dual Connectivity: Stable wireless audio and two-device pairing.
Four Scene Modes: Indoor, Outdoor, Conversation, and Restaurant.
Fast-Charging Battery: 15 minutes for 3 hours; up to 24 hours with case.
IPX5 Resistance: Protection against dust and water for reliable daily use.
Availability: Wave Lite is currently available exclusively at the Cearvol official website, with additional retail channels to follow.
About Cearvol
Cearvol is a hearing health brand that combines smart technology with human-centered design. Committed to clarity, comfort, and style, Cearvol creates AI-powered hearing solutions that help users reconnect with life’s important sounds while fostering confidence and intergenerational connection.
Press Release Service provided by 24-7PressRelease.com.
SOURCE Cearvol
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…
KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…
LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…